From: Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation
Structure
Mean t1/2,eff (h)
Median D (Gy/GBq)
Mean u(D) (%)
Lesions
69 ± 13
2.07 (0.30–16.40)
13.6 ± 3.1
Kidneys
39 ± 5
0.52 (0.21–0.88)
15.1 ± 2.8
Liver
29 ± 8
0.08 (0.06–0.14)
21.7 ± 4.8
Salivary glands
33 ± 4
0.50 (0.15–1.28)
13.4 ± 1.8